news aktuell GmbH

Visable GmbH: Record year 2021: Platform provider Visable reports 66 million euro turnover

Share

(Hamburg, Germany): – Visable, the provider of Europe’s leading B2B platforms EUROPAGES and wlw (formerly “Wer liefert was”), reports its most successful year yet: Overall, the company was able to achieve a profitable record turnover of 66 million euros. This constitutes a growth of 14 per cent compared to the previous year. "We are very satisfied and pleased with our performance in 2021, despite the ongoing COVID crisis. In particular, we were once again able to significantly increase our new customer business with a plus of 15 per cent compared to 2020 thanks to the continuous improvement of our platforms," says Visable CEO Peter F. Schmid.

Visable CEO Peter F. Schmid
Visable CEO Peter F. Schmid

Search queries on EUROPAGES and wlw: Increasingly international

Most visitors to the EUROPAGES B2B platform in 2021 came from France, Italy, Germany, Turkey and the United Kingdom. "The demand on our platforms is becoming increasingly international and is no longer limited to Europe. On wlw we recorded accesses from 180 countries, on EUROPAGES from over 200 countries. Especially the traffic from Asia is growing disproportionately on both platforms," explains Peter F. Schmid. As in previous years, the search queries on EUROPAGES came from all over the world in 2021 – including twelve from Western Sahara, eight from Vatican City and three from the American Virgin Islands.

Most of the search queries sent and received on wlw (formerly "Wer liefert was") came from Germany again, followed by Austria and Switzerland. Poland and China follow in fourth and fifth place. The five most frequently searched for product categories included mechanical engineering, respirators, foods, medical technologies, logistics and metal construction. The strongest increases in search queries were for industrial computers, power transmission elements, design systems, ethylene vinyl alcohol copolymers (EVOH) and engine monitoring systems.

Growing workforce

In 2021, Visable received around 4,200 applications, which led to almost 100 new hires across the company’s Hamburg, Paris, Berlin and Munster locations. In total, the platform provider currently employs close to 500 people.

Expanding portfolio

In 2021, Visable reacted to the growing needs of its users and expanded its existing mobile portfolio to include the Supplier App. Among other things, it allows for effortless management of the company profile as well as incoming enquiries. Its counterpart, the wlw app for purchasers, was launched at the end of 2020. Since then, it has been downloaded more than 40,000 times, with currently over 300 active users per day. The integration of the new Message Center on EUROPAGES to centralise communication between purchasers and suppliers and the inclusion of financial data in the company profiles on wlw mark further milestones in Visable’s product development.

"In 2022 we are planning, among other things, to roll out our Connect sourcing service on EUROPAGES as well," says the Visable CEO. Already implemented on wlw in 2020, this free service allows purchasers to issue a detailed request, based on which Visable experts search for and contact relevant suppliers. In this way, companies can significantly shorten their purchasing process.

Contacts

Images

Visable CEO Peter F. Schmid
Visable CEO Peter F. Schmid
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Animals' Angels: An ordeal that ends on a plate in a tourist resort: Live transports of calves to the Canary Islands10.8.2022 08:39:34 CEST | Press release

Every week, cattle are shipped to the Canary Islands under unacceptable conditions. These transports are extremely long. The animals stand on the truck for even more than 100 hours non-stop. Now, in summer, sweltering heat must be added as well as poor water supply, no or too little food, bedding of excrements and urine, lack of space, and an acrid ammonia smell. Once on the islands, the animals, only a few months old, await death in the slaughterhouse. A trade that is enhanced by subsidies and slaughter premiums.

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million4.8.2022 09:00:00 CEST | Pressemelding

(Aachen, Germany) Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal’s investigational medicine Resiniferatoxin (“RTX”). Shionogi obtained the exclusive rights to commercialise Grünenthal’s asset in Japan for pain associated with osteoarthritis of the knee. RTX is currently in Phase III of clinical development for the treatment of patients with moderate to severe pain associated with knee osteoarthritis. Osteoarthritis, a progressive and often painful joint disease, is an indication with high unmet medical need. If approved, RTX could become a well-tolerated, non-opioid therapy option for patients, providing long-lasting pain relief and functional improvement of the affected knee joints. Under the terms of the agreement, Shionogi will obtain the exclusive commercialisation rights for RTX in Japan for a total consideration of up to $ 525 million plus additional sales based payments. Thereof, Shionogi will pay $ 75 million upon signat

Make some noise for endangered species: Krombacher and Wacken Open Air present the "Growling Creatures" – the first metal band consisting of endangered animals1.8.2022 11:14:47 CEST | Pressemelding

(Krombach, Germany): What do grey seals, cuckoos, and lynx have in common? They are all rare, European native species whose survival is threatened, and they are part of the "Growling Creatures" - the first metal band consisting of endangered animals. Presented by Krombacher and the legendary metal festival Wacken Open Air (W:O:A), this summer the Growling Creatures are drawing attention to their threat and are making some noise for endangered species. "With Krombacher, we have long been committed to domestic and international species protection projects," says Peter Lemm, Head of Communications of the Krombacher brewery. "As a new partner of the Wacken Open Air, it was important for us to create an authentic connection between our sustainable commitment and entertainment with a twinkle in the eye. The Growling Creatures represent exactly this - as musical newcomers of the year, they deliver the best metal sound for the good cause." Animalistic Metal Sound On their mini-EP “Growling Cre

Avsender: R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories19.7.2022 08:36:55 CEST | Press release

(Darmstadt, Germany): As a fully integrated solution, the new and completely automated RIDA®UNITY system combines sample extraction, PCR setup, real-time PCR and result evaluation in a common workflow. The biotechnology company R-Biopharm AG announced today that it has received the CE mark and will begin selling the new, fully automated RIDA®UNITY system for molecular detection of infectious diseases throughout Europe. "With the RIDA®UNITY system, R-Biopharm is purposefully taking the path from a provider of individual solutions to a system provider in the field of molecular diagnostics," stated Christian Dreher, CEO of R-Biopharm. "We are very happy to make this system solution available to all molecular biology laboratories throughout Europe." Unique combination of different tools The RIDA®UNITY system combines the various steps in the analysis of patient samples into an integrated workflow – nucleic acid extraction, PCR setup, subsequent real-time PCR and the evaluation of the resul

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom